Triamcinolone clinical trials
Triamcinolone is named as an intervention in 6 current clinical trials in our China, USA, UK, Germany and Spain registers. 3 are recruiting patients now. The most common phase is Not applicable. The sponsor with the most trials is Beijing Tiantan Hospital (2). The most-studied condition is Parkinson Disease.
Where Triamcinolone is approved
All regulators →Of the three regulators tracked here, the first to approve Triamcinolone was the US, on 3 Dec 1957.
From the regulators' own registers: FDA Drugs@FDA, the EMA medicines list and Health Canada's Notice of Compliance database. Dates are the first listed approval of a product containing only this substance; combination products and nationally authorised EU medicines are not counted.
How Triamcinolone works
All drug targets →- Glucocorticoid receptor agonist AgonistTarget: NR3C1 nuclear receptor subfamily 3 group C member 1✓ In ChEMBL and the Guide to Pharmacology
- Acanthamoeba keratitisPhase 3
- Behcet diseasePhase 3
- COVID-19Phase 3
- COVID-19–associated multisystem inflammatory syndrome in childrenPhase 3
- Digital flexor tenosynovitisPhase 3
- IgA glomerulonephritisPhase 3
- Intraventricular hemorrhagePhase 3
- Low back painPhase 3
- Orthomyxoviridae infectious diseasePhase 3
- PainPhase 3
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL1451, CC BY-SA 3.0. Targets checked against the IUPHAR/BPS Guide to PHARMACOLOGY (2026.3.1), ligand 2870, CC BY-SA 4.0. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for Triamcinolone
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Reference identifiers for Triamcinolone
- ChEMBL
- CHEMBL1451
- DrugBank
- DB00620
- PubChem CID
- 31307
- CAS number
- 124-94-7
- FDA UNII
- 1ZK20VI6TY
- Wikidata
- Q1074056
- Wikipedia
- Triamcinolone
Codes that identify this medicine in other databases, from Wikidata (CC0), matched by its ChEMBL ID. The ATC code is the WHO classification of what the medicine is used for.
Trials by status
Trials by phase
Clinical trials of Triamcinolone
6 trialsRegisters list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Triamcinolone
13 conditionsAll 13 conditions
| Condition (as registered) | Trials |
|---|---|
| Parkinson Disease | 1 |
| Parkinson Disease 6, Early-Onset | 1 |
| Post Cataract Surgery | 1 |
| Ductal Carcinoma In Situ, DCIS | 1 |
| Knee Osteoarthritis | 1 |
| Laparoscopic Surgery | 1 |
| Laparoscopic Cholecystectomy | 1 |
| Appendectomy, Laparoscopic | 1 |
| Hernia Repair | 1 |
| Video-assisted Thoracoscopic Surgery (VATS) | 1 |
| Wedge Resection | 1 |
| Segmentectomy | 1 |
| Lobectomy of the Lungs | 1 |
Sponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Beijing Tiantan Hospital | 2 |
| AC Immune SA | 1 |
| Research Insight LLC | 1 |
| Fudan University | 1 |
| Syntr Health Technologies, Inc | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 3 | 3 |
| Clinical trials in USA | 2 | 0 |
| Clinical trials in UK | 1 | 0 |
| Clinical trials in Germany | 1 | 0 |
| Clinical trials in Spain | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Triamcinolone trials
How many clinical trials are testing Triamcinolone?
6 current trials in our China, USA, UK, Germany and Spain registers name Triamcinolone (also registered as ACI-7104.056 at B) as a drug or biological intervention, as of the registry sync on 9 November 2026. Completed and withdrawn studies are not counted.
Are Triamcinolone trials recruiting patients?
Yes. 3 of the 6 trials are recruiting: 3 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Triamcinolone clinical trials?
Beijing Tiantan Hospital (2), AC Immune SA (1), Research Insight LLC (1) and Fudan University (1), among 5 lead sponsors in total. The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Triamcinolone works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Triamcinolone works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Triamcinolone (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 9 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.